Methylene Blue: A Century-Old Dye With a Serious Interaction

Methylene blue is not a peptide. It is a thiazine dye — a small synthetic molecule first made in 1876 as a textile colourant, later found to have biological activity.

It has a genuine approved medical use, a long history, and one drug interaction serious enough that it belongs before anything else.

What it is actually approved for

Methylene blue is an approved treatment for methaemoglobinaemia — a condition where haemoglobin is oxidised into a form that cannot carry oxygen. It acts as an electron donor, converting it back.

That is a specific, well-established, mechanistically clear use, given intravenously in hospital. It bears little relationship to the reasons it is discussed in wellness contexts.

Why it appears in this space

Interest centres on mitochondrial function. Methylene blue can act as an alternative electron carrier in the mitochondrial electron transport chain, and at low concentrations this is proposed to support energy production and reduce oxidative stress.

That mechanism is genuinely interesting and is under investigation for neurological conditions. It is also the same territory as SS-31 and MOTS-c — with the difference that methylene blue is a dye and those are peptides.

The dose-response is not linear

This is an unusual and important property. At low concentrations methylene blue acts as an electron donor and antioxidant. At higher concentrations the effect reverses and it becomes a pro-oxidant.

Practical points

• It stains. Skin, surfaces, and urine, which turns blue-green. Harmless but startling if unexpected.

• Purity grades differ enormously. Industrial and laboratory-grade methylene blue is not pharmaceutical grade and may carry metal contaminants.

• G6PD deficiency is a contraindication. It can precipitate haemolysis in affected individuals.

• It interacts beyond SSRIs. The MAO-inhibiting activity is broad, so the interaction question extends past antidepressants.

Why it belongs in this discussion at all

It is sold by the same vendors, in the same catalogues, to the same audience as the peptides on this site. That is the only connection — and, as with tesofensine, 5-Amino-1MQ and enclomiphene, the grouping obscures exactly what makes it different.

None of those four is a peptide, and each carries a risk profile that has nothing in common with a growth hormone secretagogue.

Frequently asked questions

Is methylene blue a peptide?

No. It is a thiazine dye — a small synthetic molecule with no amino acids.

Why is the SSRI interaction so serious?

Methylene blue inhibits monoamine oxidase, the enzyme that breaks down serotonin. Combined with a drug that raises serotonin, the result can be serotonin syndrome.

Is aquarium-grade methylene blue the same?

No. Purity grades differ substantially, and non-pharmaceutical grades may contain contaminants including heavy metals.